ALT
Altimmune, Inc.
+0.03 (+0.93%)3.27USD1.4M成交股數636M市值–本益比(近四季)15514.9股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 26K+420% | 5K0% | 5K0% | 5K-86% | 5K-99% | 5K-17% | 5K | 37K | 362K | 6K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 18.7M | 16.2M | 18.4M | 15.0M | 17.2M | 15.8M | 19.8M | 21.2M | 21.5M | 16.9M | 18.4M | 13.3M |
| 銷售管理費用 | 7.6M | 8.1M | 10.5M | 5.9M | 5.7M | 6.0M | 5.0M | 5.6M | 5.3M | 4.3M | 4.5M | 4.8M |
| 營業利益 | −26.2M+14% | −24.2M+11% | −28.9M+17% | −20.9M-22% | −22.9M-14% | −21.8M-35% | −24.8M+10% | −26.7M+49% | −26.8M | −33.6M | −22.5M | −18.0M |
| 營業利益率 | – | – | -111,126.9% | -417,180.0% | -458,440.0% | -436,300.0% | -495,340.0% | -534,900.0% | -535,880.0% | -90,873.0% | -6,226.5% | -300,116.7% |
| 稅後淨利 | −22.8M+3% | −22.6M+15% | −27.4M+20% | −19.0M-23% | −22.1M-9% | −19.6M-38% | −22.8M+11% | −24.6M+53% | −24.4M | −31.6M | −20.7M | −16.1M |
| 淨利率 | – | – | -105,223.1% | -380,280.0% | -442,920.0% | -391,500.0% | -456,900.0% | -492,800.0% | -487,880.0% | -85,516.2% | -5,710.2% | -267,683.3% |
| 稀釋 EPS | -0.12-56% | -0.18-31% | -0.26-19% | -0.21-40% | -0.27-21% | -0.26-53% | -0.32-18% | -0.35+9% | -0.34 | -0.55 | -0.39 | -0.32 |
| 稀釋股數 | 185M | 124M | 88.1M | 89.4M | 81.5M | 75.5M | 71.1M | 70.9M | 70.8M | 53.2M | 53.6M | 50.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 63.0M | 97.6M | 43.8M | 61.2M | 183M | 49.1M | 31.5M | 57.1M | 79.0M | 135M | 86.9M | 102M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 527M | 336M | 280M | 218M | 190M | 157M | 148M | 173M | 188M | 211M | 167M | 183M |
| 有息負債 | 34.7M | 34.5M | 34.3M | 14.4M | 14.3M | – | – | – | – | – | 4.3M | 4.2M |
| 總負債 | 53.0M | 51.6M | 55.0M | 32.8M | 29.0M | 15.1M | 14.5M | 20.8M | 15.4M | 16.5M | 16.2M | 15.6M |
| 股東權益 | 474M | 284M | 225M | 186M | 161M | 142M | 133M | 153M | 173M | 194M | 150M | 168M |
| 負債比 | 10.1% | 15.4% | 19.7% | 15.0% | 15.2% | 9.6% | 9.8% | 12.0% | 8.2% | 7.9% | 9.7% | 8.5% |
| 淨現金(現金 − 有息負債) | 28.3M | 63.1M | 9.5M | 46.8M | 169M | – | – | – | – | – | 82.6M | 98.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −20.9M+24% | – | – | – | −16.8M | – | – | −16.4M | – | – | – |
| 資本支出 | – | 21K | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | −21.0M | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2018 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2018 年度 · 10.3M
| Grant | 10.3M | 99.8% | – |
|---|---|---|---|
| License And Service | 20K | 0.2% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 41K | +105.0% | −88.1M | -214,861.0% | -1.00 | −67.5M |
| FY2024 | 20K | -95.3% | −95.1M | -475,295.0% | -1.34 | – |
| FY2023 | 426K | -726.5% | −88.4M | -20,762.2% | -1.66 | −75.9M |
| FY2022 | −68K | -101.5% | −84.7M | 124,577.9% | -1.81 | −62.7M |
| FY2021 | 4.4M | -46.1% | −97.1M | -2,201.4% | -2.35 | −90.4M |
| FY2020 | 8.2M | +41.1% | −49.0M | -599.2% | -1.91 | −34.5M |
| FY2019 | 5.8M | -43.8% | −20.5M | -353.7% | -1.60 | −9.6M |
| FY2018 | 10.3M | – | −39.2M | -379.2% | -15.16 | −10.4M |